The present invention is directed to a compound of the formula (I); or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
申请公布号
CA2658525(C)
申请公布日期
2013.02.19
申请号
CA20072658525
申请日期
2007.07.31
申请人
NOVARTIS AG
发明人
CHAREST, MARK G.;CHEN, CHRISTINE HIU-TUNG;CHEN, ZHUOLIANG;DAI, MIAO;HE, FENG;LEI, HUANGSHU;PHAM, LY LUU;SHARMA, SUSHIL KUMAR;STRAUB, CHRISTOPHER SEAN;WANG, RUN-MING DAVID;YANG, FAN;ZAWEL, LEIGH
